Skip to main content

Overview

P-32 decays by beta emission with a half-life of 14.26 days. It is typically produced in nuclear reactors by neutron irradiation of sulfur-32. The resulting P-32 is then chemically separated and incorporated into radiopharmaceuticals or used in research. Supply chain considerations involve the availability of nuclear reactors, sulfur targets, and radiochemistry facilities. Logistical challenges include the transport and handling of radioactive materials. Accessibility for developing countries is influenced by the specialised facilities and regulatory requirements.

Maturity

P-32 production and application are well-established, with use in medical and research settings.

Safety considerations

P-32 is a radioactive isotope that emits beta radiation, requiring careful handling procedures and physical shielding to minimise radiation exposure.

Security considerations

All radioactive isotopes can be misused, and as such, robust security protocols around chain of custody, inventory management, and physical security are critical.

Safeguarding considerations

Due to the absence of nuclear materials, IAEA safeguards are not applicable.